Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association

The glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recommended as a monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the position statement of the Korean Diabetes Association 2017 for pharmacological therapy. Many randomized clinical trials and systemat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Metab J
Päätekijät: Kim, Hyun Jin, Park, Seok O, Ko, Seung-Hyun, Rhee, Sang Youl, Hur, Kyu-Yeon, Kim, Nan-Hee, Moon, Min Kyong, Lee, Byung-Wan, Kim, Jin Hwa, Choi, Kyung Mook
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Diabetes Association 2017
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741550/
https://ncbi.nlm.nih.gov/pubmed/29272081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2017.41.6.423
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia